Red Tortoise LLC’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.68K Hold
241
﹤0.01% 346
2025
Q4
$5.23K Hold
241
﹤0.01% 376
2025
Q3
$3.65K Hold
241
﹤0.01% 438
2025
Q2
$2.72K Hold
241
﹤0.01% 475
2025
Q1
$2.43K Hold
241
﹤0.01% 468
2024
Q4
$2.85K Hold
241
﹤0.01% 460
2024
Q3
$2.78K Hold
241
﹤0.01% 465
2024
Q2
$2.55K Hold
241
﹤0.01% 471
2024
Q1
$2.54K Hold
241
﹤0.01% 472
2023
Q4
$2.71K Buy
+241
New +$2.35K ﹤0.01% 405

Other funds holding ROIV

Red Tortoise LLC's ROIV Position: Q1 2026 in Review

Red Tortoise LLC held its Roivant Sciences (ROIV) position steady in Q1 2026 at 241 shares worth $6.68K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

Red Tortoise LLC first reported a position in ROIV in Q4 2023 and has held it in 10 quarters since. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Red Tortoise LLC held 241 shares of Roivant Sciences worth $6.68K as of Q1 2026.
  • Red Tortoise LLC left its Roivant Sciences share count unchanged in Q1 2026.
  • Roivant Sciences made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #346 holding.
  • Red Tortoise LLC first reported a position in Roivant Sciences in Q4 2023 and has held it in 10 quarters since.
  • 444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.